Project Grant HT94252510605
Award Date 11/1/25
Completion Date 10/31/28
Dollars Obligated $324K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
- This federal Project Grant award for $968,904.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Texas Southwestern Medical Center (UT Southwestern) to target the DNA damage response as a potential treatment for clear cell renal cell carcinoma. The project will be conducted at UT Southwestern's facilities in Dallas, Texas over a 4-year period from July 1, 2024 to June 30, 2028. This...
- This Project Grant award of $1,106,902.00 was provided by the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award supports research at the University of Texas Southwestern Medical Center in Dallas, Texas to "delineate tumor-immune contexture that shapes clear cell renal cell carcinoma (ccRCC) metastatic progression and response to immunotherapy." The 3-year project aims to advance the understanding of the tumor-immune...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,107,000 three-year Project Grant to The University of Texas Southwestern Medical Center in Dallas, TX. The grant, effective September 1, 2023, will fund research to characterize the epigenetic and metabolic vulnerabilities in clear cell renal cell carcinoma (ccRCC) with VHL gene deficiencies, and explore the therapeutic potential of these findings. The University of Texas System will...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $999,096.00 to The University of Texas Southwestern Medical Center to conduct research on "Targeting DNA Damage Response to Treat Clear Cell Renal Cell Carcinoma." The award period runs from July 1, 2024 to June 30, 2028. The research aims to develop new treatments for clear cell renal cell carcinoma, a type of kidney cancer, by investigating...
- This federal Project Grant award of $319,800.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Texas Southwestern Medical Center, located in Dallas, TX. The award supports a research project titled "NOVEL HIF-2 REGULATORS AND THERAPEUTIC TARGETS FOR KIDNEY CANCER" with a performance period from November 1, 2025 to October 31, 2028. The project aims to conduct advanced biomedical research to...
- This $834,798 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports PET imaging research of HIF 2A in renal cancer at The University of Texas Southwestern Medical Center in Dallas, Texas. The research project aims to develop new diagnostic and treatment approaches for kidney cancer, which is a key focus area for this Defense Department program. The award will fund basic, translational, and clinical research...
- This Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Texas Southwestern Medical Center. The $1,312,000 grant, with a period of performance from July 1, 2024 to June 30, 2028, will support research on biomarkers and mechanisms of acquired resistance to immunotherapy for renal cell carcinoma. This work aims to improve understanding and treatment of this form of kidney cancer, which is a...
- This $1,565,298.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The University of Texas Health Science Center at San Antonio to target the METTL3 enzyme in order to overcome drug resistance in metastatic clear cell renal cell carcinoma. The project aims to develop innovative medical solutions to address this critical health challenge for military personnel and the broader public. The award period runs...
- This Project Grant award, totaling $1,229,936, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The University of Texas Southwestern Medical Center, doing business as Southwestern Medical School, located in Dallas, Texas. The award supports research aimed at "Imaging Strategies and Biomarkers for Detecting the Metabolic Interplay of Glutamine and Aspartate in RCC" over the project period from August 1, 2025 to July...
- The Department of the Army Medical Command awarded a $1,189,000 Project Grant to The University of Texas Southwestern Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research titled "RECURRENT GENOMIC ALTERATIONS DRIVING CLEAR CELL RENAL CELL CARCINOMA DEVELOPMENT." The grant period runs from August 1, 2022 to July 31, 2026. The Military Medical Research and Development program aims to advance biomedical research that transforms...